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Metabolic effects of 4-pentenoate on isolated dog kidney
tubules
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Metabolic effects of 4-pentenoate on isolated dog kidney tubules. The
effects of 4-pentenoate (0.01 to 10 mM) were studied on suspensions of
cortical tubules and of thick ascending limbs (TAL) prepared from dog
kidneys. When cortical tubules were incubated with 1 m glutamine,
4-pentenoate accelerated glutamine uptake, ammoniagenesis, and the
production of aiphaketoglutarate, lactate and pyruvate, but decreased
gluconeogenesis. With 5 ms glutamine, the marked accumulation of
aiphaketoglutarate reversed the net fluxes through the alanine and
aspartate aminotransferases. When cortical tubules or TAL were incu-
bated with lactate, its utilization and gluconeogenesis (in cortical
tubules) were markedly decreased by 4-pentenoate. The mitochondrial
NAD+/NADH ratio was markedly increased by 4-pentenoate in corti-
cal tubules but not in TAL. The production of '4C02 from '4C[1J-
pyruvate or '4C-[l]-alphaketoglutarate was decreased by approximately
60% by 4-pentenoate in cortical tubules but not in TAL. In cortical
tubules, these findings are best explained by depletion of mitochondrial
free CoA, inhibition of pyruvate and aiphaketoglutarate dehydroge-
nases and decreased mitochondrial NADH. By contrast, in TAL,
accumulation of reducing equivalents probably resulted from the me-
tabolism of 4-pentenoate itself.
We have shown in a recent in vivo study in the dog that the
infusion of 4-pentenoate induced a complete Fanconi's syn-
drome with proximal renal tubular acidosis [1]. In this study,
4-pentenoate accelerated glutamine utilization and ammonia
production and decreased lactate utilization and probably glu-
coneogenesis in the intact kidney. Previous in vitro studies have
shown that 4-pentenoate, an unsaturated short-chain fatty acid,
depletes the mitochondrial CoA pool through its sequestration
into inert and stable derivative(s) of 4-pentenoate [2, 3]. The
lack of free CoA then inhibits the CoA-dependent mitochon-
dna! oxidation of fatty acids [4, 5], pyruvate [6, 7] and alpha-
ketoglutarate [8] and the decreased acetyl CoA diminishes
gluconeogenesis [5, 9—11]. The 4-pentenoate-induced increment
in ammoniagenesis observed in our in vivo study [1] (as well as
in rat renal cortical slices [10]) probably reflects a metabolic
compensatory response to these effects of 4-pentenoate.
The present study was undertaken to throw some light on the
sites and mechanisms of the metabolic response induced by
4-pentenoate along the nephron. Our study was carried out in
dog tubules to remove extrarenal factors that might influence
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renal glutamine and lactate metabolism. In order to investigate
the tissue specificity of the metabolic effects of 4-pentenoate,
both proximal tubules and thick ascending limbs were studied.
Our data demonstrate that in proximal tubules 4-pentenoate
significantly accelerated renal glutamine metabolism (and am-
monia production) to aiphaketoglutarate which accumulated
and markedly reduced the gluconeogenesis, the renal utilization
of lactate and the fluxes through pyruvate and aiphaketoglu-
tarate dehydrogenases. In thick ascending limbs, a fall in the
utilization of lactate was also induced by 4-pentenoate but no
accumulation of alphaketoglutarate was noted and the fluxes
through pyruvate and aiphaketoglutarate dehydrogenases were
not altered. It is concluded that the toxic effect of 4-pentenoate
is mostly restricted to the proximal nephron.
Methods
Experimental procedures
Metabolism o.f various substrates. Suspensions of cortical
tubules (> 85% proximal) and of thick ascending limbs (> 95%
purity) were prepared from the kidneys obtained from mongrel
dogs. Following anesthesia with sodium pentobarbital (30 mg/
kg), the dogs were intubated and connected to a Harvard
respirator. Both kidneys were rapidly removed, immediately
placed in ice-cold Krebs-Henseleit saline and cut into slices.
The superficial cortex and the red inner stripe of the outer
medulla were carefully dissected out with fine scissors. Each
tissue fraction was then sliced with a Stadie-Riggs microtome
and digested with collagenase during 45 minutes (cortex) or 60
minutes (red medulla) according to a procedure already de-
scribed [12, 13]. Approximately 60 mg wet weight of renal
cortical tubules or 30 to 40 mg wet weight of tubules of thick
ascending limbs of Henle were incubated in a final volume of 4
ml of gassed (95% 02 — 5% C02) Krebs-Henseleit saline
containing 2.5 g % of dialyzed bovine albumin (fraction V) and
adjusted to pH 7.4.
For each type of tubule, the incubation medium contained
either 0, 0.01, 0.1, 1 or 10 mM 4-pentenoate, neutralized to a pH
of 7.4. In six experiments performed with cortical tubules, the
exogenous metabolic substrates also placed in the incubation
medium were either 1 or 5 m L-glutamine together with 0.1 or
0.5 m't L-glutamate or 1 or 5 mri L-lactate together with 0.1 or
0.5 mM pyruvate in order to obtain a physiological ratio. The
substrate combination of glutamine and lactate was also stud-
ied. Four additional experiments were performed with 1 or S
mM L-glutamate (with or without 1 or 5 m L-lactate) and six
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Fig. 1. Renal cortical metabolism of
glutamine 1 mi in the absence (A) and in the
presence of JO mi 4-pentenoate (B). Means
for glutamine extracted and glutamate,
alphaketoglutarate, lactate, and pyruvate
produced are given in Table 1; these values
and the metabolic fluxes between these
intermediates are expressed as micromoles
per gram tissue wet weight per 60 minutes.
The minimal utilization of aspartate and
production of malate and alanine are not
presented in this figure. Numbers close to
each arrow represent mean fluxes calculated
from measured values for reaction(s)
represented by the arrow. Solid arrows mean
fluxes accelerated by 4-pentenoate and open
arrows decreases in these fluxes after 4-
pentenoate. Various metabolites are shown to
join pyruvate (oxaloacetate) pool, supporting
gluconeogenesis and oxidation.
other studies were carried out with 1 or 5 mrsi malate or
glycerol. In six experiments performed with thick ascending
limbs, the substrates placed in the incubation medium were 1 or
5 mM lactate together with 0.1 or 0.5 mM pyruvate, respec-
tively. In all cases the tubules were incubated in 25 ml sili-
conized erlenmeyer flasks for 0 or 60 minutes at 37°C with
constant shaking (40 rpm) and the incubation was stopped by
the addition of 40% perchloric acid (final concentration of 5%).
Oxygen consumption. In five additional experiments per-
formed with 10 mM glutamine and 10 m lactate in the medium,
the effect of 1 mrvt 4-pentenoate on the oxygen consumption by
the suspension of renal cortical tubules was measured polaro-
graphically using an oxygen electrode and a specially designed
oxymetric chamber [141. Four similar experiments were per-
formed using a suspension of thick ascending limbs incubated
with 10 m lactate.
Metabolism of '4C-[1]-pyruvate and '4C-[1]-alphaketoglu-
tarate. To study the production of '4C02 from the metabolism
of 'C-[ li-pyruvate or '4C-[ 1]-alphaketoglutarate, tracer
amounts (0.5 1iCi/flask) of labelled pyruvate or aiphaketoglu-
tarate were added respectively to 2 m cold pyruvate or
alphaketoglutarate. For comparison purposes, five experiments
were performed with dog cortical tubules or thick ascending
limbs incubated in a final volume of 4 ml of Krebs-Henseleit
saline. In each tissue, 2 m substrates were studied with or
without 1 mM 4-pentenoate.
Analytical methods
The acid supernatant was neutralized with potassium hydrox-
ide and used to determine the concentrations of glutamine,
glutamate, aiphaketoglutarate, ammonia, malate, aspartate, al-
anine, lactate, pyruvate and glucose by enzymatic assays as
previously reported [15). Uptake or production of each metab-
olite was calculated using corresponding zero time values and
expressed per gram wet weight and per 60 minutes of incubation
(these processes having been previously demonstrated to be
linear).
For experiments using '4C-[l]-substrates, the incubation was
performed at 37°C in flasks fitted with an empty center well
fitted with a dry filter paper butterfly. The dead space was filled
with 95% 02:5% CO2. At the end of the incubation (0, 15, 30,60
minutes), the center well was filled up with 0.5 ml of 20% KOH
and 0.25 ml of 40% perchloric acid was injected in the incuba-
tion medium with a long needle through the rubber cap closing
the flasks. The incubation was continued at 4°C for two hours in
order to collect all the CO2 (gas + bicarbonate). The KOH and
the filter paper were then collected and the well was washed
twice with 1 ml of water. All the KOH and washing volumes
were added in 15 ml of scintillation cocktail (Aquasol, Packard)
in counting vials (a gel is formed under these conditions). The
vials were left for 48 hours in the dark at 4°C and counted. A
sample of the incubation medium was counted and the rest was
deproteinized and neutralized as described above. The specific
activity obtained at the beginning of the incubation was mea-
sured from the initial pyruvate (or aiphaketoglutarate) concen-
tration and DPM. The recovery of DPM as soluble metabolites
+ CO2 was 100 2.0% (N = 5).
Calculations
The metabolic fates (production of aminoacids or organic
anions, gluconeogenesis, or oxidation to C02) of added sub-
strates was estimated from a carbon balance [16). When the
sum of amino acids, organic anions and C3-glucose was smaller
than the total extraction of carbon substrates, the difference
was assumed to represent net oxidation to CO2. The apparent
free NAD+/NADH ratio of the cytosolic and mitochondrial
compartments were calculated respectively from the lactate
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Table 1. Effects of 4-pentenoate on the metabolism of renal cortical tubules incubated with glutamine
4-Pentenoate
concentration,
mM Glutamine Glutamate KG Ammonia Malate Aspartate
Glutamine 1 mM
0 —36.4 3.3 7.1 1.9 0.6 0.2 84.7 5.7 —0.1 0.04 —2.0 1.1
0.01 —37.0 3.2 7.7 2.3 0,6 0.2 92.3 4.9 —0.1 0.1 —2.1 1.0
0.1 —35.3 3.8 9.7 2.5 0.5 0.2 85.4 7.2 —0.1 0.1 —1.6 1.1
1 —50.2 4.2" 11.9 l.7 15.5 0,9b 99.6 5.9k 0.6 0.3 —2.8 1.1
10 —55.0 4.4" 11.1 1.9 20.2 13b 109.5 7,2b 0.9 Ø58 3.4 0.88
Glutamine 5 mM
0 —110.5 17.8 41.2 3.8 1.4 0.3 190.7 17.8 0.03 0.1 8.0 2.2
0.01 —119.1 22.0 41.9 3.8 1.3 0.3 186.4 14.1 0.3 0.1 11.5 5.0
0.1 —110.7 19.6 42.3 4.5 1.4 0.4 201.8 25.9 0.2 0.1 8.5 2.3
1 —91.7 17.5 42.3 4.1 23.4 1.4" 157.3 9.7 0.8 0.4 1.3 1.68
10 —117.7 19.9 43.2 5.0 31.8 17b 175.3 12.7 1.4 0.5" 0.1 1.88
Values are means SE (N = 6 dogs). Results are expressed as micromoles per gram tissue wet weight per 60 minutes and are corrected for zero
time.
A negative sign represents uptake of a metabolite whereas a positive sign depicts production. Abbreviation KG is aiphaketoglutarate.
Significant difference from value obtained in the absence of 4-pentenoate in the flask: 8 P < 0.05; "P < 0.01
dehydrogenase and glutamate dehydrogenase near-equilibrium
systems [17].
Statistical analysis
Unless otherwise specified, the term significant is used
throughout the paper to describe a difference with a P value of
less than 0.05. A variance analysis for repeated measurements
on one level was performed, comparisons of all mean values
being obtained by the Newman-Keuls procedure [18].
Results
Effects of 4-pentenoate on the metabolism of isolated renal
cortical tubules incubated with various substrates
Glutamine. In the absence of 4-pentenoate, a significant
fraction of the glutamine added to the medium was metaboli-
cally utilized, whereas glutamate, ammonia and glucose accu-
mulated in the flasks (Table 1). The addition of 0.01 or 0.1 mM
4-pentenoate to the incubation medium did not change glu-
tamine metabolism. However, concentration of 1 or 10 mst
4-pentenoate significantly accelerated the uptake of 1 mM
glutamine (from 36 to 55 smol g hr ')and the production
of ammonia and alphaketoglutarate. By contrast, the uptake of
5 mM glutamine and the production of ammonia were not
increased by 4-pentenoate. In the presence of 10 m 4-pen-
tenoate, almost half of the aiphaketoglutarate produced from
glutamine metabolism was found as such in the flask instead of
being further metabolized, suggesting a block at the aiphaketo-
glutarate dehydrogenase level (Fig. 1). The fall in the produc-
tion of alanine and aspartate with 5 ms glutamine (Fig. 2A)
reflected the transaminations block induced by alphaketoglu-
tarate accumulation. The transformation of alphaketoglutarate
into pyruvate remained virtually unaffected by the addition of
4-pentenoate (Fig. 1). Lactate accumulation became quantita-
tively comparable to that of pyruvate instead of the normal 10 to
1 ratio observed in control conditions, indicating a reduction in
cytoplasmic NADH. Gluconeogenesis was modestly increased
by 0.1 mxi 4-pentenoate, but markedly reduced by higher
concentrations. The small amount of glutamine oxidation to
CO2 in control conditions was entirely suppressed by 4-pen-
tenoate. The mitochondrial NAD+/NADH ratio calculated
from the glutamate dehydrogenase system was markedly in-
creased by 1 or 10 mis 4-pentenoate. Thus, the addition of
4-pentenoate led to a significant oxidation of the redox state of
both cytosolic and mitochondrial compartments.
Lactate. In the absence of 4-pentenoate, a net utilization of
lactate, pyruvate and aspartate as well as a net production of
glutamate, ammonia, alanine and glucose were observed (Table
2). With 5 m lactate, the higher concentration increased
through an anaplerotic effect on the Krebs cycle, the alphake-
toglutarate available for transformation into glutamate, there-
fore reducing the endogenous ammonia production.
The addition of 1 or 10 mis 4-pentenoate drastically reduced
the utilization of lactate and pyruvate, the gluconeogenic flux
and the apparent oxidation of these organic anions. The mito-
chondrial metabolism of pyruvate into oxaloacetate or acetyl
CoA was thus drastically reduced by 4-pentenoate, suggesting a
block at the pyruvate carboxylase and pyruvate dehydrogenase
steps. With 5 mrt lactate, 4-pentenoate increased ammonia
production while reducing in a reciprocal fashion the produc-
tion of alanine. The mitochondrial NAD+/NADH ratio was
markedly increased by 1 or 10 ms'i 4-pentenoate (Fig. 3A). The
cytosolic NAD+/NADH ratio calculated from the lactate de-
hydrogenase system was also increased by 1 or 10 m 4-pen-
tenoate (Fig. 3B).
When glutamine and lactate were placed together in the
incubation medium, the changes induced by 4-pentenoate in the
uptake or production of the various metabolites were in most
instances similar to those observed either with glutamine alone
(that is, increased glutamine uptake, and production of ammo-
nia and malate) or with lactate alone (that is, reduced lactate
uptake and gluconeogenesis). However with 5 mM concentra-
tions of glutamine and lactate, the transamination of pyruvate
into alanine was so important in the absence of 4-pentenoate
(Fig. 2B) that no net GLDH deaminating flux was observed,
possibly because pyruvate became the major source of reducing
equivalents. This GLDH flux appeared with the addition of
4-pentenoate which decreased the availability of reducing
equivalents.
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Table 1. Continued
Alanine Lactate Pyruvate Glucose
0.9 0.5 0.4 0.2 1.0 0.2 10.1 0.8
0.5 0.5 0.6 0.3 0.9 0.1 9.9 1.1
1.0 0.5 0.4 0.2 0.9 0.2 12.0 0.9
2.9 0.8" 11.5 08b 8.4 1.1" 3.8 04b
2.2 0.7a 9•3 o.7 8.3 10b 3•4 0b
10.7 1.4 5.6 0.8 4.5 1.0 15.7 1.2
10.7 1.4 5.9 0.8 4.4 0.9 15.8 1.3
9.9 1.1 4.1 0.8 4.2 0.9 17.1 1.3
4.6 0.9" 11.8 07" 9.0 0.8" 3.7 0.4"
3.4 0.9" 93 ()4b 7.9 0.7" 3.2 0.4"
Other substrates. With 1 mis'i glutamate in the medium, the
addition of 10 mrvi 4-pentenoate accelerated glutamate uptake
from 9 to 18 jsmol g' hr', induced an accumulation of
alphaketoglutarate but did not significantly change ammonia
production. With 5 m glutamate in the medium, the addition of
4-pentenoate did not change significantly glutamate uptake and
ammonia production but induced a marked accumulation of
alphaketoglutarate. Four-pentenoate also increased the produc-
tion of malate, lactate, pyruvate and alanine but reduced
markedly gluconeogenesis from 12 to 0.4 jsmol g' hr1.
When a concentration of 1 or 5 m of either malate or
glycerol was placed in the incubation medium, the addition of
4-pentenoate markedly reduced gluconeogenesis in a fashion
comparable to that observed with other gluconeogenic sub-
strates such as glutamine, glutamate and lactate: glucose pro-
duction decreased from 12 to 0.5 mol g' hr' with 1 mM
malate and from 23 to 6 jsmol g' hr' with 1 m glycerol.
Effects of 4-pentenoate on the metabolism of isolated thick
ascending limbs incubated with lactate
In the absence of 4-pentenoate and with lactate in the
medium, a marked lactate uptake was observed (Table 3).
Except for a modest increase in alanine production, no signifi-
cant changes in the uptake or production of metabolites were
induced by the addition of 0.01 or 0.1 mM 4-pentenoate to a
suspension of thick ascending limbs incubated with lactate.
However, findings apparently similar to those observed with
cortical tubules were found with concentrations of 4-pentenoate
of 1 or 10 msi. Four-pentenoate reduced markedly the net
utilization of lactate (Fig. 4). The net pyruvate production was
changed into a net pyruvate uptake (pyruvate was present
initially at 1/10 of the lactate concentration), indicating a redox
change. Indeed concomitant fall in pyruvate concentration and
rise in lactate concentration, increasing markedly the lactate!
pyruvate ratio and decreasing the cytoplasmic NAD+/NADH
ratio, were observed. This redox shift contrasts with the
oxidation observed with proximal tubules and indicates an
accumulation of NADH, probably produced by the metabolism
of 4-pentenoate itself. Indeed, both the mitochondrial and the
cystolic NAD+/NADH ratios were decreased by the addition
of 1 or 10 mri 4-pentenoate (Fig. 3). The lack of accumulation of
pyruvate and aiphaketoglutarate in the presence of 4-pen-
tenoate in this tissue suggests the absence of a metabolic block
at the alphaketoglutarate dehydrogenase and pyruvate dehydro-
genase levels, in contrast to observations made with cortical
tubules.
Effects of 4-pentenoate on the respiration of renal cortical
tubules and thick ascending limbs
In renal cortical tubules, 4-pentenoate (1 mM) slightly in-
creased the oxygen consumption from 384.7 to 403.8 mol/g
tissue wet wt/60 mm. Thus the NADH availability for the
respiratory chain was preserved following 4-pentenoate addi-
tion, in part through an accelerated conversion of glutamine
into aiphaketoglutarate. In thick ascending limbs, the oxygen
consumption was also slightly increased by the addition of 1 m
4-pentenoate (from 354.4 to 368.8 .tmol!g tissue wet wt/60 mm).
Effects of 4-pentenoate on the metabolism of '4C-[1]-pyruvate
or '4C-[lj-alphaketoglutarate
Renal cortical tubules. The production of '4C0, from the
metabolism of '4C-[1]-pyruvate, measuring the rate of pyruvate
oxidation to acetyl CoA, was linearly related to time and was
reduced by 62% from 71.7 3.7 to 27.6 3.3 tmol g' hr1
by the addition of 4-pentenoate. Pyruvate uptake was simulta-
neously decreased from 89.3 1.3 to 47.2 4.8
smol g' hr1 by 4-pentenoate. Glucose synthesis was im-
mediately and markedly inhibited by 4-pentenoate. The lactate!
pyruvate ratio in the flasks exceeded 6 in the absence of
4-pentenoate (without reaching the equilibrium value around
10), but was only 0.6 in the presence of 4-pentenoate which
interfered with the production of NADH from pyruvate by
suppressing the oxidation of pyruvate.
The production of 14C02 from the metabolism of '4C-[l]-
aiphaketoglutarate, measuring the rate of alphaketoglutarate
oxidation to succinyl CoA, was linearly related to time and was
decreased (with alphaketoglutarate uptake) by 55% from 71.7
2.5 to 32.6 1.7 mol g' hr1 by 4-pentenoate. Glucose
production was again suppressed by 4-pentenoate. Lactate
production was stimulated by 4-pentenoate, indicating the
suppression of pyruvate oxidation.
Thick ascending limbs. The production of '4C02 from the
metabolism of 14C-[1]-pyruvate was linearly related to time
(93.2 11.9 mol g1 hr1) and was minimally affected by
the addition of 4-pentenoate. Pyruvate utilization (133.4 19.7
mol g' hr I) was faster than in proximal tubules but was
not changed by 4-pentenoate. No glucose synthesis was ob-
served in this non-gluconeogenic nephron segment. The accu-
mulation of lactate in the flask was unaffected by 4-pentenoate.
Both in the absence or presence of 4-pentenoate, the lactate!
pyruvate ratio remained around 1, a value much lower than the
equilibrium value around 10. Therefore the oxidation of pyru-
vate and the production of NADH were not impaired by
4-pentenoate in this nephron segment.
The production of '4C02 from the metabolism of 14C-[l]-
alphaketoglutarate was minimal in thick ascending limbs (7.6
2.3 smol g1 hr'). Aiphaketoglutarate uptake and net lac-
tate production also remained very small. The minimal metab-
olism of alphaketoglutarate in this nephron segment suggests a
low permeability of the cell membrane to this organic anion.
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Discussion
Effects of4-pentenoate on glutamine metabolism in proximal
tubules
The present study demonstrates that the addition of 1 or 10
mM 4-pentenoate to the incubation medium significantly in-
creased the uptake of 1 ms't glutamine and the production of
ammonia by proximal cortical tubules in the dog, in a fashion
comparable to that observed in vivo in the dog [1] and in rat
renal cortical slices [101. These findings were also reminiscent
of those previously observed with valproate [19, 20] as well as
with maleate [21, 22], a metabolic inhibitor known to deplete
the mitochondrial CoA pool [231. This accelerated ammonia-
genesis contrasts with the decreased glutamine metabolism
produced by short- or long-chain fatty acids [24] and resulted in
aiphaketoglutarate accumulation. Because the renal production
of aspartate and alanine was not increased, the observed
accumulation of aiphaketoglutarate cannot be accounted for by
an accelerated transamination, but probably resulted from an
increased oxidative deamination of glutamate into alphaketo-
glutarate together with a block at the level of alphaketoglutarate
dehydrogenase. This block was ascertained by the marked
decrease by 4-pentenoate in the rate of '4C02 production from
'4C-[ li-aiphaketoglutarate.
In fact, the data of the present study appear to be best
accounted for by the following sequence of events in the
4-pentenoate-intoxicated mitochondria of proximal tubular
cells. First, the metabolism of 4-pentenoate depleted mitochon-
drial free CoA [25] through its sequestration in inert and stable
derivative(s) of 4-pentenoate [2, 3]. Second, the CoA-depen-
dent mitochondrial oxidation of at least three substrates was
impaired: long-chain fatty acids [4, 26], pyruvate [6] and alpha-
ketoglutarate [8]. In our study, a block at the alphaketoglutarate
Table 2. Effects of4-pentenoate on the metabolism of renal cortical tubules incubated with lactate
4-Pentenoate
concentration,
mM Glutamine Glutamate KG Ammonia Malate Aspartate
Lactate 1 mM
0 —0.1 0.3 6.6 1.3 0.5 0.2 31.4 3.8 —0.1 0.1 —3.9 1.2
0.01 —0.1 0.3 6.8 1.4 0,4 0.2 33.4 6.1 —0.1 0.1 —3.8 1.2
0.1 —0.2 0.3 6.9 2.0 0.5 0.2 36.7 5.8 —0.1 0.1 —3.8 1.5
1 —0.9 0.3 —0.2 l.2' 2.6 0.9a 28.5 4.8 0.2 0.l —3.8 1.4
10 —1.1 0.3 —1.0 10b 3.2 l.oa 28.0 4.5 0.3 01b —3.6 1.8
Lactate 5 mM
0 —0.7 0.3 13.5 1.7 1.4 0.3 11.5 1.7 —0.1 0.1 —4.8 1.3
0.01 —0.6 0.4 12.6 1.5 1.3 0.4 11.5 1.8 0 0.1 —4.8 1.4
0.1 0.8 2.0 11.6 1.5 1.3 0.4 10.8 1.7 0.1 0.1 —5.2 1.2
1 —0.8 0.3 —0.6 1.1" 4.5 Ø9 31.3 5.3'' 0.2 o.la —4.8 1.3
10 —1.2 0.4 —1.1 11b 4.8 l.2' 27.2 35b 0.5 02b —5.0 1.4
Aiphaketoglutarate
NH4 + NADH
Values are means SE (N 6 dogs). Results are expressed as micromoles per gram tissue wet weight per 60 minutes and are corrected for zero
time.
A negative sign represents uptake of a metabolite whereas a positive sign depicts production. Abbreviation KG is alphaketoglutarate.
Significant difference from value obtained in the absence of 4-pentenoate in the flask: a P < 0.05; b P < 0.01
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Fig. 2. Metabolicfluxes (micromoles per
gram tissue wet weight per 60 minutes) in
renal cortical tubules of the three near-
equilibrium reactions between glutamate and
alphaketoglutarate catalyzed by glutamate
dehydrogenase, alanine and aspartate
aminotransferases with (left panel) or without
10 mM 4-pentenoate (right panel). The upper
panel represents the renal cortical tubules
incubated with 5 mM glutamine, whereas
these tubules incubated with 5 mM glutamine
and 5 msi lactate are depicted in the lower
panel.Glutamate
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Table 2. Continued
Alanine Lactate Pyruvate Glucose
3.1 0.8 —61.2 4.5 —4.6 0.5 18.8 1.3
3.9 1.0 —62.1 4.3 —4.5 0.5 19.6 1.5
5.0 1.5 —60.0 4.6 —4.3 0.5 19.7 1.5
6.7 0.9a —16.4 37b 4.3 1.4"
4.5 0.8 —9.1 36b 2.4 14b 2.8 04b
23.2 1.6 —139.8 15.3 —17.5 1.5 30.6 2.1
23.3 1.5 —138.7 16.0 —17.5 1.4 29.9 2.1
24.0 1.6 —131.6 16.0 —18.3 0.9 27.3 1.9
12.0 12" —48.1 87b 4.0 2.3" 5.7 0.6"
8.6 10b —35.2 10.4" 0 23b 4.5 0.3"
dehydrogenase level is suggested by: (1) the important amount
of aiphaketoglutarate produced by glutamine metabolism recov-
ered as such in the flask instead of being further metabolized;
(2) the decreased oxidation of '4C-[1]-alphaketoglutarate.
Third, this inhibition of mitochondrial metabolism decreased
the supply of mitochondrial reducing equivalents, as reflected
by the striking increase in the mitochondrial NAD+INADH
ratio observed in renal cortical tubules (Fig. 3B) and by the
striking fall in lactate production when pyruvate is presented to
the tubules. Only a modest rise was observed in vivo [1],
probably because the predicted concentration of 4-pentenoate
(before any metabolism) in the renal tissue was much less than
I mM. Fourth, the oxidative deamination of glutamate into
aiphaketoglutarate and ammonia, an important residual source
of NADH in these 4-pentenoate-intoxicated mitochondria, was
accelerated. This increased deaminating GLDH flux occurred
despite the marked accumulation of alphaketoglutarate, and
must have resulted from the marked fall in mitochondrial
NADH. This mechanism provided enough reducing equivalents
to maintain a normal rate of respiration, that is, of the ATP
turnover but not a normal lactate/pyruvate (NADINADH) ratio.
Fifth, the resulting fall in intramitochondrial glutamate, a well-
known inhibitor of the phosphate-dependent glutaminase [27],
de-inhibited this enzyme and stimulated the deamidation of
glutamine into glutamate and ammonia, and secondarily the
entry of glutamine inside the mitochondria. This stimulation of
glutamine metabolism was seen in the presence of 1 mM
glutamine but was not observed with 5 mM glutamine, suggest-
ing that in this condition enough alternative substrates were
present to interfere with the toxic effect of 4-pentenoate.
Effects of 4-pentenoate on lactate and pyruvate metabolism
When renal cortical tubules and thick ascending limbs were
incubated with lactate and pyruvate, 4-pentenoate markedly
reduced the renal utilization of these two substrates in a fashion
similar to that recently observed with valproate in these two
preparations [19, 28]. This decreased oxidation of lactate and
pyruvate might theoretically result from four mechanisms [29]:
(1) an inhibited entry of lactate and pyruvate into renal tubular
cells; (2) an increased cytoplasmic NADH decreasing lactate
oxidation into pyruvate; (3) an inhibitory entry of pyruvate into
mitochondria; and (4) an inhibition of pyruvate dehydrogenase
activity. The latter was directly demonstrated by the marked
fall in the rate of '4C02 production from '4C-[lJ-pyruvate in
renal cortical tubules.
However, different mechanisms must account for the de-
creased utilization of lactate in renal cortical tubules and thick
ascending limbs (Fig. 5). In renal cortical tubules (mostly
proximal cells), the mitochondrial transformation of pyruvate
into acetyl CoA became minimal in the presence of 4-pen-
tenoate, suggesting a block at the level of pyruvate dehydroge-
nase. Thus the metabolism of 4-pentenoate in proximal cells
interferes with the oxidation of pyruvate and limited the gener-
ation of reducing equivalents, presumably through CoA seques-
tration in 3-keto-4-pentenoyl CoA, an intermediate along the
minor pathway of 4-pentenoate oxidation [3]. A mitochondrial
CoA depletion resulting from the cellular metabolism of 4-pen-
tenoate [2, 3] could indeed account for this inhibition. The
secondary fall of acetyl CoA also explains the inhibition of
pyruvate carboxylase and oxaloacetate production.
By contrast, in thick ascending limbs, the near-equilibrium
oxidation of lactate into pyruvate was displaced in favor of
lactate in the presence of 4-pentenoate. This inhibition probably
resulted from the observed accumulation of reducing equiva-
lents in both mitochondrial and (through the malate/aspartate
shuttle) cytosolic compartments. Indeed, by contrast with the
cortical tubules, 4-pentenoate did not alter the metabolic fluxes
through pyruvate and aiphaketoglutarate dehydrogenases
('4CO2 production) and markedly increased the lactate/pyru-
vate ratio.
The renal metabolism of 4-pentenoate is thus different in
cortical tubules and thick ascending limbs. Following its entry
inside the mitochondria, 4-pentenoate can be metabolized by
two different pathways [3]. The first two reactions are common
to both pathways: activation of 4-pentenoate to 4-pentenoyl
CoA which is oxidized to 2,4-pentadienoyl CoA. If enough
NADPH is available, 2,4-pentadienoyl CoA is reduced through
its major pathway to 3-pentenoyl CoA and is further metabo-
lized into propionyl CoA and acetyl CoA. If NADPH is not
available, 2,4-pentadienoyl CoA is hydrated through its minor
pathway into 3-hydroxy-4-pentenoyl CoA which is oxidized to
3-keto-4-pentenoyl CoA, an inhibitory metabolite of fatty acid
oxidation at the level of 3-ketoacyl-CoA thiolase [3].
Effects of 4-pentenoate on glucose metabolism
In the presence of lactate, glutamine, glutamate, malate or
glycerol, the decreased glucose accumulation in the incubation
medium indicates a decreased gluconeogenesis. Such a fall was
also previously reported in isolated rat hepatocytes using pyru-
vate [9] and rat renal cortical slices utilizing various substrates
[10, 11]. The lack of mitochondrial acetyl CoA, an obligatory
allosteric regulator of pyruvate carboxylase [30], would inhibit
the gluconeogenesis from lactate. The lack of cytosolic NADH
(Fig. 3B) would decrease gluconeogenesis from glutamine and
glutamate through inhibition of the glyceraldehyde-3-phosphate
dehydrogenase [3, 5]. This may also account for the reduction
of gluconeogenesis from malate. However this decreased glu-
coneogenesis cannot result only from the 4-pentenoate-induced
inhibition of fatty acid oxidation and the decreased production
of acetyl CoA and NADH in proximal tubules. Indeed, the
marked inhibition by 4-pentenoate of gluconeogenesis from
glycerol also suggests either a direct effect of 4-pentenoate or a
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A B
Fig. 3. Mitochondrial (A) and cytoplasmic (B)
NADINADH ratios as calculated
respectively from the glutamate
dehydrogenase and lactate dehydrogenase
systems when renal cortical tubules (• •)
or thick ascending limbs (O----O) are
incubated with 5 mM lactate and various
concentrations of 4-pentenoate.
Table 3. Effects of 4-pentenoate on the metabolism of thick ascending limbs incubated with lactate
4-Pentenoate
concentration,
m Lactate Pyruvate LIP ratio Glutamate KG Ammonia Aspartate Alanine Malate
Lactate 1 mM
0 —71.9 8.4 10.0 1.9 3.2 0.4 4.2 0.9 1.5 0.2 4.7 0.8 —0.9 0.7 3.7 0.5 0.1 0.1
0.01 —72.3 7,6 9.8 2.2 3.3 0.4 5.1 1.4 2.1 0.3 5.3 0.9 —0.8 0.7 4.3 0.7 0.1 0.2
0.1 —64.7 8.4 9.4 1.6 3.4 0.4 2.7 1.4 1.6 0.2 6.1 1.3 —0.6 0.8 5.2 1.oa 0.2 0.3
1
—59.6 9.0" 5.8 1.6 5.2 0.9 2.7 1.5 0.7 o.la 6.8 1.la —0.3 0.8k 4.2 0.5 0.2 0.2
10 —28.3 7.5" —7.7 0.5" 18.8 1.9' 0.8 1.5" 0.9 0.1 9.2 1.4" —1.2 0.7 2.0 05b 0.2 0.1
Lactate 5 mM
0 —112.5 24.0 2.2 6.9 8.6 0.9 5.7 1.1 2.8 0.5 2.5 0.6 —0.9 0.6 6.1 0.8 0.1 0.2
0.01 —100.4 27.1 0.3 6.3 9.0 0.9 5.8 1.3 3.1 0.4 3.2 0.8 —1.0 0.4 6.2 0.9 0.1 0.4
0.1 —91.0 24.la 0.2 3.1 8.9 0.6 5.1 1.3 2.8 0.2 2.8 1.0 —1.1 0.4 6.5 1.1 0.1 0.2
1 —94.0 25.8 —7.7 5.4 10.1 0.9 4.1 1.4 1.7 0.3" 4.1 0.8 —0.7 0.4 6.1 1.0 —0.1 0.5
10 —55.7 22.9" —33.2 3.0" 18.4 1.6" 4.4 1.5 1.1 0.2" 4.6 1.1" —1.0 0.4 3.7 0.7" 0.3 0.1
Values are means SE (N = 6dogs). Results are expressed as micromoles per gram tissue wet weight per 60 minutes and are corrected for zero
time.
A negative sign represents uptake of a metabolite whereas a positive sign depicts production. Abbreviations are: KG, alphaketoglutarate; L/P
ratio, concentration of lactate over that of pyruvate in micromoles per gram of tubules.
Significant difference from value obtained in the absence of 4-pentenoate in the flask; a P < 0.05; b P < 0.01
A Control
72 10Lactate > Pyruvate/
Alanine Co2
B 4-Pentenoate
28 8
Lactate > Pyruvate <
Alanine Co2
Fig. 4. Renal metabolism of lactate 1 mM in
thick ascending limbs in the absence (A) and
in the presence of 10 mw 4-pentenoate (B).
Means for lactate and pyruvate extracted and
alanine and pyruvate produced are given in
Table 4 and these metabolic fluxes are
expressed as micromoles per gram tissue wet
weight per 60 minutes. Numbers close to each
arrow represent mean fluxes calculated from
measured values for reaction(s) represented
by the arrow.
role of the intracellular ATP depletion induced by the inhibition glutarate dehydrogenase would also decrease the malate avail-
of the Krebs cycle, able for its malic enzyme-dependent oxidation and the produc-
In summary, a striking difference was observed between the tion of NADPH. Because the first reaction in the major pathway
effects of 4-pentenoate in renal cortical tubules and thick of the mitochondrial metabolism of 4-pentenoate is NADPH-
ascending limbs. This discrepancy might be explained by the dependent [31, the lack of NADPH might favor the minor
following hypothesis. In proximal tubules, the low hexokinase pathway and the production of the inhibitory metabolite 3-keto-
activity [12] might decrease the amount of glucose 6-phosphate 4-pentenoyl CoA. The mitochondrial CoA depletion would
available for the pentose phosphate pathway and the production inhibit the CoA-dependent oxidation of fatty acids, pyruvate
of NADPH. Furthermore, the block at the level of aiphaketo- and aiphaketoglutarate and the mitochondrial production of
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A Renal cortex
NADH and NADPH and consequently increase the mitochon-
drial NAD+/NADH ratio.
In thick ascending limbs, the high hexokinase activity [121
might increase the glucose 6-phosphate availability for the
pentose phosphate pathway or other pathway producing
NADPH. This might have favored the major pathway of the
mitochondrial metabolism of 4-pentenoate. Through this path-
way, no inert CoA derivatives of 4-pentenoate are produced.
The /3-oxidation of 4-pentenoate would generate substantial
amounts of NADH and therefore competitively decrease the
oxidation of other substrates such as lactate and pyruvate.
However, additional experiments will be required to confirm
this hypothesis and to elucidate the exact mechanisms respon-
sible for the different effects of 4-pentenoate. These different
findings in renal cortical tubules and thick ascending limbs
underline the metabolic heterogeneity of these two nephron
segments and emphasize the specific toxic effects of certain
agents along the nephron. The decreased proximal reabsorption
of various solutes observed in vivo and reproducing an exper-
imental Fanconi's syndrome [11 probably results from this
mostly proximal toxicity of 4-pentenoate.
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Fig. 5. Cytoplasmic and mitochondrial effects
of 4-pentenoate. In the renal cortex, the
depletion of mitochondrial reducing
equivalents (resulting from the inhibition of
pyruvate dehydrogenase and
alphaketoglutarate dehydrogenase) stimulated
the oxidative deamination of glutamate into
alphaketoglutarate. In thick ascending limbs,
the mitochondrial metabolism of 4-pentenoate
increased the reducing equivalents in the
mitochondrial and (through the
malate/aspartate shuttle) cytosolic
compartments. Abbreviations are: LAC,
lactate; PYR, pyruvate; aKG,
alphaketoglutarate; GLU, glutamate; GLN,
glutamine; 4-P, 4-pentenoate; AcCoA, acetyl
CoA.
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